Carl Zeiss Meditec AG (fra:AFXA) Share Price

Company Profile

Business description
Carl Zeiss Meditec is one of the largest visioncare technology companies in the world. Its ophthalmology segment, which made up about 75% of sales in 2025, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, intraocular lenses, and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. The microsurgery segment is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% share, Zeiss is the clear leader in this market.
Contact
Goschwitzer Strasse 51-52
JenaTH07745
DEU
T: +49 3641220115
https://www.zeiss.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
30 September 2026
Employees
5,798

Recommended

Discounted exit raises investor concerns.

Yingqi Tan, CFA | 21 September 2026

The data and AI company is one of the world’s strongest private companies, but a PitchBook report says it’s unattractive at the current price.

Jacob Robbins | 21 September 2026

Morningstar analysts’ take on the takeover for this undervalued industrial player.

Esther Holloway | 20 September 2026

Index	Last price	Change	% Change
All Ordinaries	8,951.00	31.90	0.36%
CAC 40	8,187.97	49.03	0.60%
DAX 40	25,746.37	171.36	0.67%
Dow JONES (US)	52,048.83	366.19	0.71%
FTSE 100	10,757.64	18.63	0.17%
HKSE	25,087.75	45.04	0.18%
NASDAQ	27,122.09	599.55	2.26%
Nikkei 225	65,018.95	882.70	1.38%
NZX 50 Index	13,875.48	54.28	0.39%
S&P 500	7,764.70	0.00	0.00%
S&P/ASX 200	8,757.80	25.90	0.30%
SSE Composite Index	3,952.13	2.22	0.06%